Summary:
- Researchers have utilized artificial intelligence to design a novel drug candidate that successfully reduced markers of biological aging in human blood samples.
- The study demonstrates the growing intersection of machine learning and pharmacology, highlighting how AI can accelerate the discovery of compounds that influence cellular rejuvenation and longevity.